Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade.

Geuijen CAW, De Nardis C, Maussang D, Rovers E, Gallenne T, Hendriks LJA, Visser T, Nijhuis R, Logtenberg T, de Kruif J, Gros P, Throsby M.

Cancer Cell. 2018 May 14;33(5):922-936.e10. doi: 10.1016/j.ccell.2018.04.003.

2.

Translational PK-PD modeling analysis of MCLA-128, a HER2/HER3 bispecific monoclonal antibody, to predict clinical efficacious exposure and dose.

de Vries Schultink AHM, Doornbos RP, Bakker ABH, Bol K, Throsby M, Geuijen C, Maussang D, Schellens JHM, Beijnen JH, Huitema ADR.

Invest New Drugs. 2018 Dec;36(6):1006-1015. doi: 10.1007/s10637-018-0593-x. Epub 2018 May 5.

3.

Identification of target membrane proteins as detected by phage antibodies.

Geuijen CA, Bakker AQ, de Kruif J.

Methods Mol Biol. 2009;528:141-58. doi: 10.1007/978-1-60327-310-7_11.

PMID:
19153691
4.

Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.

Throsby M, Ter Meulen J, Geuijen C, Goudsmit J, de Kruif J.

Expert Rev Vaccines. 2007 Apr;6(2):183-91. Review.

PMID:
17408368
5.

Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus.

Throsby M, Geuijen C, Goudsmit J, Bakker AQ, Korimbocus J, Kramer RA, Clijsters-van der Horst M, de Jong M, Jongeneelen M, Thijsse S, Smit R, Visser TJ, Bijl N, Marissen WE, Loeb M, Kelvin DJ, Preiser W, ter Meulen J, de Kruif J.

J Virol. 2006 Jul;80(14):6982-92.

6.

Affinity ranking of antibodies using flow cytometry: application in antibody phage display-based target discovery.

Geuijen CA, Clijsters-van der Horst M, Cox F, Rood PM, Throsby M, Jongeneelen MA, Backus HH, van Deventer E, Kruisbeek AM, Goudsmit J, de Kruif J.

J Immunol Methods. 2005 Jul;302(1-2):68-77.

PMID:
15992810
7.

A proteomic approach to tumour target identification using phage display, affinity purification and mass spectrometry.

Geuijen CA, Bijl N, Smit RC, Cox F, Throsby M, Visser TJ, Jongeneelen MA, Bakker AB, Kruisbeek AM, Goudsmit J, de Kruif J.

Eur J Cancer. 2005 Jan;41(1):178-87.

PMID:
15618003
8.

C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.

Bakker AB, van den Oudenrijn S, Bakker AQ, Feller N, van Meijer M, Bia JA, Jongeneelen MA, Visser TJ, Bijl N, Geuijen CA, Marissen WE, Radosevic K, Throsby M, Schuurhuis GJ, Ossenkoppele GJ, de Kruif J, Goudsmit J, Kruisbeek AM.

Cancer Res. 2004 Nov 15;64(22):8443-50.

9.

Dynamics of the alpha6beta4 integrin in keratinocytes.

Geuijen CA, Sonnenberg A.

Mol Biol Cell. 2002 Nov;13(11):3845-58.

10.

Association of the tetraspanin CD151 with the laminin-binding integrins alpha3beta1, alpha6beta1, alpha6beta4 and alpha7beta1 in cells in culture and in vivo.

Sterk LM, Geuijen CA, van den Berg JG, Claessen N, Weening JJ, Sonnenberg A.

J Cell Sci. 2002 Mar 15;115(Pt 6):1161-73. Erratum in: J Cell Sci 2002 Jun 15;115(Pt 12):2615.

11.

Yersinia enterocolitica YopP-induced apoptosis of macrophages involves the apoptotic signaling cascade upstream of bid.

Denecker G, Declercq W, Geuijen CA, Boland A, Benabdillah R, van Gurp M, Sory MP, Vandenabeele P, Cornelis GR.

J Biol Chem. 2001 Jun 8;276(23):19706-14. Epub 2001 Mar 14.

12.

Yersinia enterocolitica can deliver Yop proteins into a wide range of cell types: development of a delivery system for heterologous proteins.

Boyd AP, Grosdent N, Tötemeyer S, Geuijen C, Bleves S, Iriarte M, Lambermont I, Octave JN, Cornelis GR.

Eur J Cell Biol. 2000 Oct;79(10):659-71.

PMID:
11089914
13.
14.

The virulence plasmid of Yersinia, an antihost genome.

Cornelis GR, Boland A, Boyd AP, Geuijen C, Iriarte M, Neyt C, Sory MP, Stainier I.

Microbiol Mol Biol Rev. 1998 Dec;62(4):1315-52. Review.

15.

The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model.

Willems RJ, Kamerbeek J, Geuijen CA, Top J, Gielen H, Gaastra W, Mooi FR.

Vaccine. 1998 Feb;16(4):410-6.

PMID:
9607064
16.

Identification and characterization of heparin binding regions of the Fim2 subunit of Bordetella pertussis.

Geuijen CA, Willems RJ, Hoogerhout P, Puijk WC, Meloen RH, Mooi FR.

Infect Immun. 1998 May;66(5):2256-63.

17.

Role of the Bordetella pertussis minor fimbrial subunit, FimD, in colonization of the mouse respiratory tract.

Geuijen CA, Willems RJ, Bongaerts M, Top J, Gielen H, Mooi FR.

Infect Immun. 1997 Oct;65(10):4222-8.

18.

The major fimbrial subunit of Bordetella pertussis binds to sulfated sugars.

Geuijen CA, Willems RJ, Mooi FR.

Infect Immun. 1996 Jul;64(7):2657-65.

19.

Binding of FimD on Bordetella pertussis to very late antigen-5 on monocytes activates complement receptor type 3 via protein tyrosine kinases.

Hazenbos WL, van den Berg BM, Geuijen CW, Mooi FR, van Furth R.

J Immunol. 1995 Oct 15;155(8):3972-8.

PMID:
7561105
20.

Bordetella pertussis fimbriae bind to human monocytes via the minor fimbrial subunit FimD.

Hazenbos WL, Geuijen CA, van den Berg BM, Mooi FR, van Furth R.

J Infect Dis. 1995 Apr;171(4):924-9.

PMID:
7706820
21.

Mutational analysis of the Bordetella pertussis fim/fha gene cluster: identification of a gene with sequence similarities to haemolysin accessory genes involved in export of FHA.

Willems RJ, Geuijen C, van der Heide HG, Renauld G, Bertin P, van den Akker WM, Locht C, Mooi FR.

Mol Microbiol. 1994 Jan;11(2):337-47.

PMID:
8170396
22.

Isolation of a putative fimbrial adhesin from Bordetella pertussis and the identification of its gene.

Willems RJ, Geuijen C, van der Heide HG, Matheson M, Robinson A, Versluis LF, Ebberink R, Theelen J, Mooi FR.

Mol Microbiol. 1993 Aug;9(3):623-34.

PMID:
8105363

Supplemental Content

Loading ...
Support Center